PULMONX CORPORATION (LUNG) Net margin 2018–2025
PULMONX CORPORATION (LUNG) net profit margin by fiscal year — reported net income divided by reported revenue.
-59.7%FY2025 · since FY2018: -92.4% → -59.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.7% | +7.6 pp |
| FY2024 | -67.3% | +21.3 pp |
| FY2023 | -88.6% | +21.2 pp |
| FY2022 | -109.8% | -9.3 pp |
| FY2021 | -100.5% | -2.0 pp |
| FY2020 | -98.5% | -35.0 pp |
| FY2019 | -63.5% | +28.9 pp |
| FY2018 | -92.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice